Role for the adenovirus IVa2 protein in packaging of viral DNA
Although it has been demonstrated that the adenovirus IVa2 protein binds to the packaging domains on the viral chromosome and interacts with the viral L1 52/55-kDa protein, which is required for viral DNA packaging, there has been no direct evidence demonstrating that the IVa2 protein is involved in...
Uloženo v:
| Vydáno v: | Journal of virology Ročník 75; číslo 21; s. 10446 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.11.2001
|
| Témata: | |
| ISSN: | 0022-538X |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Although it has been demonstrated that the adenovirus IVa2 protein binds to the packaging domains on the viral chromosome and interacts with the viral L1 52/55-kDa protein, which is required for viral DNA packaging, there has been no direct evidence demonstrating that the IVa2 protein is involved in DNA packaging. To understand in greater detail the DNA packaging mechanisms of adenovirus, we have asked whether DNA packaging is serotype or subgroup specific. We found that Ad7 (subgroup B), Ad12 (subgroup A), and Ad17 (subgroup D) cannot complement the defect of an Ad5 (subgroup C) mutant, pm8001, which does not package its DNA due to a mutation in the L1 52/55-kDa gene. This indicates that the DNA packaging systems of different serotypes cannot interact productively with Ad5 DNA. Based on this, a chimeric virus containing the Ad7 genome except for the inverted terminal repeats and packaging sequence from Ad5 was constructed. This chimeric virus replicates its DNA and synthesizes Ad7 proteins, but it cannot package its DNA in 293 cells or 293 cells expressing the Ad5 L1 52/55-kDa protein. However, this chimeric virus packages its DNA in 293 cells expressing the Ad5 IVa2 protein. These results indicate that the IVa2 protein plays a role in viral DNA packaging and that its function is serotype specific. Since this chimeric virus cannot package its own DNA, but produces all the components for packaging Ad7 DNA, it may be a more suitable helper virus for the growth of Ad7 gutted vectors for gene transfer. |
|---|---|
| AbstractList | Although it has been demonstrated that the adenovirus IVa2 protein binds to the packaging domains on the viral chromosome and interacts with the viral L1 52/55-kDa protein, which is required for viral DNA packaging, there has been no direct evidence demonstrating that the IVa2 protein is involved in DNA packaging. To understand in greater detail the DNA packaging mechanisms of adenovirus, we have asked whether DNA packaging is serotype or subgroup specific. We found that Ad7 (subgroup B), Ad12 (subgroup A), and Ad17 (subgroup D) cannot complement the defect of an Ad5 (subgroup C) mutant, pm8001, which does not package its DNA due to a mutation in the L1 52/55-kDa gene. This indicates that the DNA packaging systems of different serotypes cannot interact productively with Ad5 DNA. Based on this, a chimeric virus containing the Ad7 genome except for the inverted terminal repeats and packaging sequence from Ad5 was constructed. This chimeric virus replicates its DNA and synthesizes Ad7 proteins, but it cannot package its DNA in 293 cells or 293 cells expressing the Ad5 L1 52/55-kDa protein. However, this chimeric virus packages its DNA in 293 cells expressing the Ad5 IVa2 protein. These results indicate that the IVa2 protein plays a role in viral DNA packaging and that its function is serotype specific. Since this chimeric virus cannot package its own DNA, but produces all the components for packaging Ad7 DNA, it may be a more suitable helper virus for the growth of Ad7 gutted vectors for gene transfer.Although it has been demonstrated that the adenovirus IVa2 protein binds to the packaging domains on the viral chromosome and interacts with the viral L1 52/55-kDa protein, which is required for viral DNA packaging, there has been no direct evidence demonstrating that the IVa2 protein is involved in DNA packaging. To understand in greater detail the DNA packaging mechanisms of adenovirus, we have asked whether DNA packaging is serotype or subgroup specific. We found that Ad7 (subgroup B), Ad12 (subgroup A), and Ad17 (subgroup D) cannot complement the defect of an Ad5 (subgroup C) mutant, pm8001, which does not package its DNA due to a mutation in the L1 52/55-kDa gene. This indicates that the DNA packaging systems of different serotypes cannot interact productively with Ad5 DNA. Based on this, a chimeric virus containing the Ad7 genome except for the inverted terminal repeats and packaging sequence from Ad5 was constructed. This chimeric virus replicates its DNA and synthesizes Ad7 proteins, but it cannot package its DNA in 293 cells or 293 cells expressing the Ad5 L1 52/55-kDa protein. However, this chimeric virus packages its DNA in 293 cells expressing the Ad5 IVa2 protein. These results indicate that the IVa2 protein plays a role in viral DNA packaging and that its function is serotype specific. Since this chimeric virus cannot package its own DNA, but produces all the components for packaging Ad7 DNA, it may be a more suitable helper virus for the growth of Ad7 gutted vectors for gene transfer. Although it has been demonstrated that the adenovirus IVa2 protein binds to the packaging domains on the viral chromosome and interacts with the viral L1 52/55-kDa protein, which is required for viral DNA packaging, there has been no direct evidence demonstrating that the IVa2 protein is involved in DNA packaging. To understand in greater detail the DNA packaging mechanisms of adenovirus, we have asked whether DNA packaging is serotype or subgroup specific. We found that Ad7 (subgroup B), Ad12 (subgroup A), and Ad17 (subgroup D) cannot complement the defect of an Ad5 (subgroup C) mutant, pm8001, which does not package its DNA due to a mutation in the L1 52/55-kDa gene. This indicates that the DNA packaging systems of different serotypes cannot interact productively with Ad5 DNA. Based on this, a chimeric virus containing the Ad7 genome except for the inverted terminal repeats and packaging sequence from Ad5 was constructed. This chimeric virus replicates its DNA and synthesizes Ad7 proteins, but it cannot package its DNA in 293 cells or 293 cells expressing the Ad5 L1 52/55-kDa protein. However, this chimeric virus packages its DNA in 293 cells expressing the Ad5 IVa2 protein. These results indicate that the IVa2 protein plays a role in viral DNA packaging and that its function is serotype specific. Since this chimeric virus cannot package its own DNA, but produces all the components for packaging Ad7 DNA, it may be a more suitable helper virus for the growth of Ad7 gutted vectors for gene transfer. |
| Author | Imperiale, M J Zhang, W Low, J A Christensen, J B |
| Author_xml | – sequence: 1 givenname: W surname: Zhang fullname: Zhang, W organization: Department of Microbiology and Immunology, Center for Gene Therapy and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109-0942, USA – sequence: 2 givenname: J A surname: Low fullname: Low, J A – sequence: 3 givenname: J B surname: Christensen fullname: Christensen, J B – sequence: 4 givenname: M J surname: Imperiale fullname: Imperiale, M J |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11581412$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1j19LwzAUxfMwcX_0K0jwwbfW3JukTV-EMadOhoLo8K1k6e2sds1sVsFvb8UJh3Ph8ONwz5gNGt8QY-cgYgA0l_erRZzqGCEGoVQS9a5VjELAgI2EQIy0NK9DNg7hvQ97RB2zIYA2oABH7OrJ18RL3_L9G3FbUOO_qrYLfLGyyHet31PV8F476z7spmo23Je8R2zNrx-mJ-yotHWg08OdsJeb-fPsLlo-3i5m02XkZKYhwhI0ZYnOSBORlGsQOsPEyUSTM2TQFJRKCVaoNFFap4VA5xRAaaxdg8EJu_jr7T_67Cjs820VHNW1bch3IU8BwRj5C54dwG69pSLftdXWtt_5_2L8Ad3JV4M |
| CitedBy_id | crossref_primary_10_1128_JVI_76_18_9194_9206_2002 crossref_primary_10_1128_JVI_77_6_3586_3594_2003 crossref_primary_10_1371_journal_ppat_1010588 crossref_primary_10_1016_j_bpc_2008_11_014 crossref_primary_10_1016_j_neurobiolaging_2006_06_014 crossref_primary_10_1128_JVI_02097_06 crossref_primary_10_1016_j_antiviral_2010_08_002 crossref_primary_10_1186_1471_2164_9_213 crossref_primary_10_1016_S0042_6822_02_00085_5 crossref_primary_10_1016_j_virusres_2015_07_026 crossref_primary_10_1038_gt_2014_92 crossref_primary_10_1128_JVI_77_11_6255_6264_2003 crossref_primary_10_1128_JVI_78_12_6459_6468_2004 crossref_primary_10_1128_JVI_79_4_2559_2572_2005 crossref_primary_10_1016_j_coviro_2021_03_006 crossref_primary_10_1128_JVI_79_5_2831_2838_2005 crossref_primary_10_1007_s11262_005_0031_y crossref_primary_10_1002_jcb_20523 crossref_primary_10_1038_s41598_017_07997_w crossref_primary_10_1016_S0042_6822_03_00011_4 crossref_primary_10_3390_v8120333 crossref_primary_10_1128_JVI_02455_08 crossref_primary_10_1016_j_virol_2004_03_008 crossref_primary_10_1128_JVI_01584_06 crossref_primary_10_1016_j_jviromet_2006_11_022 crossref_primary_10_1128_JVI_77_9_5127_5135_2003 crossref_primary_10_1128_JCM_00282_09 crossref_primary_10_1128_JVI_00040_08 crossref_primary_10_1016_j_jviromet_2009_04_010 crossref_primary_10_1016_j_virol_2005_01_048 crossref_primary_10_1016_j_jmb_2005_03_002 crossref_primary_10_1128_spectrum_00785_22 crossref_primary_10_1016_j_virol_2004_10_041 crossref_primary_10_1128_JVI_00467_11 crossref_primary_10_1089_hum_2004_15_1022 crossref_primary_10_1016_j_virol_2006_09_005 crossref_primary_10_1128_JVI_00882_08 crossref_primary_10_1016_j_nano_2007_10_084 crossref_primary_10_1111_cla_12422 crossref_primary_10_1128_JVI_02884_13 crossref_primary_10_1016_j_virol_2003_12_025 crossref_primary_10_1128_JVI_01061_09 crossref_primary_10_1007_s11262_008_0281_6 crossref_primary_10_1002_smll_200900467 crossref_primary_10_1128_JVI_00123_06 crossref_primary_10_1016_j_virol_2004_06_011 crossref_primary_10_1016_S0042_6822_03_00493_8 crossref_primary_10_1016_j_virol_2005_08_024 crossref_primary_10_1016_j_virol_2005_03_003 crossref_primary_10_1016_j_virusres_2004_04_007 crossref_primary_10_1128_JVI_01453_15 crossref_primary_10_1128_JVI_80_4_1965_1971_2006 crossref_primary_10_1038_s44318_023_00021_0 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1128/JVI.75.21.10446-10454.2001 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Biology |
| ExternalDocumentID | 11581412 |
| Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: HL64762 – fundername: NIGMS NIH HHS grantid: GM34902 – fundername: NHLBI NIH HHS grantid: R01 HL064762 |
| GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAYJJ ABPPZ ACGFO ACNCT ADBBV AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CGR CS3 CUY CVF D0S DIK E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A NPM O9- OHT OK1 P2P PKN RHF RHI RNS RPM RSF TR2 UCJ UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM 7X8 AAFWJ AAGFI AFPKN |
| ID | FETCH-LOGICAL-c3951-2f15e9659e5eee33b105926c365ec8e828de7331a04764557d02cc411f8aab182 |
| IEDL.DBID | 7X8 |
| ISSN | 0022-538X |
| IngestDate | Sun Nov 09 14:04:41 EST 2025 Wed Feb 19 01:19:28 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 21 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3951-2f15e9659e5eee33b105926c365ec8e828de7331a04764557d02cc411f8aab182 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/114618 |
| PMID | 11581412 |
| PQID | 71218838 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_71218838 pubmed_primary_11581412 |
| PublicationCentury | 2000 |
| PublicationDate | 20011101 |
| PublicationDateYYYYMMDD | 2001-11-01 |
| PublicationDate_xml | – month: 11 year: 2001 text: 20011101 day: 1 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of virology |
| PublicationTitleAlternate | J Virol |
| PublicationYear | 2001 |
| References | 10965494 - Mol Med. 2000 Mar;6(3):179-95 9032378 - J Virol. 1997 Mar;71(3):2408-16 1136138 - Virology. 1975 Jul;66(1):10-24 11339900 - Hum Gene Ther. 2001 May 1;12(7):839-46 9151856 - J Virol. 1997 Jun;71(6):4626-37 9371579 - J Virol. 1997 Dec;71(12):9206-13 9499056 - J Virol. 1998 Mar;72(3):2022-32 1527852 - J Virol. 1992 Oct;66(10):6133-42 3003240 - J Gen Virol. 1986 Feb;67 ( Pt 2):321-32 10947937 - Mol Ther. 2000 Aug;2(2):105-13 1731109 - J Virol. 1992 Feb;66(2):723-31 9621078 - J Virol. 1998 Jul;72(7):6138-45 1508674 - Nucleic Acids Res. 1992 Aug 11;20(15):3881-9 9733823 - J Virol. 1998 Oct;72(10):7860-70 902315 - Cell. 1977 Sep;12(1):243-9 11119572 - J Virol. 2001 Jan;75(1):45-51 10840055 - Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7482-7 8207818 - J Virol. 1994 Jul;68(7):4450-7 6579530 - Proc Natl Acad Sci U S A. 1983 Nov;80(21):6446-50 7555084 - Curr Top Microbiol Immunol. 1995;199 ( Pt 3):59-80 3785188 - Mol Cell Biol. 1986 Jun;6(6):2115-24 4139804 - Virology. 1973 Mar;52(1):130-47 7533647 - Immunity. 1994 Aug;1(5):433-42 9274715 - Gene Ther. 1997 May;4(5):393-400 8971023 - J Virol. 1996 Dec;70(12):8934-43 3418700 - J Mol Biol. 1988 May 5;201(1):57-67 7884845 - J Virol. 1995 Apr;69(4):2004-15 2325200 - J Virol. 1990 May;64(5):2047-56 10684284 - J Virol. 2000 Mar;74(6):2687-93 8648763 - J Virol. 1996 Jun;70(6):4173-8 8599194 - Virology. 1996 Mar 1;217(1):11-22 2760976 - J Virol. 1989 Sep;63(9):3612-21 10364357 - J Virol. 1999 Jul;73(7):6048-55 7218423 - J Virol. 1981 Jan;37(1):139-47 9032314 - J Virol. 1997 Mar;71(3):1842-9 8817325 - Hum Mol Genet. 1996 Jul;5(7):913-21 21416352 - Methods Mol Biol. 1991;7:109-28 8942974 - Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13565-70 8940636 - Gene Ther. 1996 Nov;3(11):965-72 5669983 - Virology. 1968 Sep;36(1):126-36 9094606 - J Virol. 1997 May;71(5):3375-84 6871990 - Cell. 1983 Jul;33(3):683-93 11177555 - Hum Gene Ther. 2001 Jan 20;12(2):181-91 7143575 - J Virol. 1982 Nov;44(2):530-7 8650161 - Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5731-6 9050832 - Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1645-50 7877990 - Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1401-5 8794347 - J Virol. 1996 Oct;70(10):7030-8 886304 - J Gen Virol. 1977 Jul;36(1):59-74 8676512 - J Virol. 1996 Jul;70(7):4805-10 8709289 - J Virol. 1996 Sep;70(9):6497-501 6547205 - Mol Cell Biol. 1984 May;4(5):867-74 8709283 - J Virol. 1996 Sep;70(9):6463-7 8627656 - J Virol. 1996 Mar;70(3):1396-405 8642665 - J Virol. 1996 Apr;70(4):2378-86 9658073 - J Virol. 1998 Aug;72(8):6339-47 6871991 - Cell. 1983 Jul;33(3):695-703 9444984 - J Virol. 1998 Feb;72(2):926-33 7555060 - Curr Top Microbiol Immunol. 1995;199 ( Pt 1):47-66 7418007 - Cell. 1980 Jul;20(3):787-95 |
| References_xml | – reference: 4139804 - Virology. 1973 Mar;52(1):130-47 – reference: 8940636 - Gene Ther. 1996 Nov;3(11):965-72 – reference: 8971023 - J Virol. 1996 Dec;70(12):8934-43 – reference: 1731109 - J Virol. 1992 Feb;66(2):723-31 – reference: 10364357 - J Virol. 1999 Jul;73(7):6048-55 – reference: 6871990 - Cell. 1983 Jul;33(3):683-93 – reference: 886304 - J Gen Virol. 1977 Jul;36(1):59-74 – reference: 8817325 - Hum Mol Genet. 1996 Jul;5(7):913-21 – reference: 9371579 - J Virol. 1997 Dec;71(12):9206-13 – reference: 7555060 - Curr Top Microbiol Immunol. 1995;199 ( Pt 1):47-66 – reference: 10684284 - J Virol. 2000 Mar;74(6):2687-93 – reference: 9032314 - J Virol. 1997 Mar;71(3):1842-9 – reference: 10840055 - Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7482-7 – reference: 9274715 - Gene Ther. 1997 May;4(5):393-400 – reference: 11119572 - J Virol. 2001 Jan;75(1):45-51 – reference: 8709289 - J Virol. 1996 Sep;70(9):6497-501 – reference: 9499056 - J Virol. 1998 Mar;72(3):2022-32 – reference: 3785188 - Mol Cell Biol. 1986 Jun;6(6):2115-24 – reference: 3418700 - J Mol Biol. 1988 May 5;201(1):57-67 – reference: 8676512 - J Virol. 1996 Jul;70(7):4805-10 – reference: 1508674 - Nucleic Acids Res. 1992 Aug 11;20(15):3881-9 – reference: 9658073 - J Virol. 1998 Aug;72(8):6339-47 – reference: 7143575 - J Virol. 1982 Nov;44(2):530-7 – reference: 11177555 - Hum Gene Ther. 2001 Jan 20;12(2):181-91 – reference: 8650161 - Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5731-6 – reference: 7555084 - Curr Top Microbiol Immunol. 1995;199 ( Pt 3):59-80 – reference: 8648763 - J Virol. 1996 Jun;70(6):4173-8 – reference: 7877990 - Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1401-5 – reference: 7533647 - Immunity. 1994 Aug;1(5):433-42 – reference: 9050832 - Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1645-50 – reference: 8709283 - J Virol. 1996 Sep;70(9):6463-7 – reference: 7418007 - Cell. 1980 Jul;20(3):787-95 – reference: 6547205 - Mol Cell Biol. 1984 May;4(5):867-74 – reference: 6871991 - Cell. 1983 Jul;33(3):695-703 – reference: 902315 - Cell. 1977 Sep;12(1):243-9 – reference: 7218423 - J Virol. 1981 Jan;37(1):139-47 – reference: 8627656 - J Virol. 1996 Mar;70(3):1396-405 – reference: 9032378 - J Virol. 1997 Mar;71(3):2408-16 – reference: 10947937 - Mol Ther. 2000 Aug;2(2):105-13 – reference: 6579530 - Proc Natl Acad Sci U S A. 1983 Nov;80(21):6446-50 – reference: 1527852 - J Virol. 1992 Oct;66(10):6133-42 – reference: 9621078 - J Virol. 1998 Jul;72(7):6138-45 – reference: 9733823 - J Virol. 1998 Oct;72(10):7860-70 – reference: 7884845 - J Virol. 1995 Apr;69(4):2004-15 – reference: 8207818 - J Virol. 1994 Jul;68(7):4450-7 – reference: 11339900 - Hum Gene Ther. 2001 May 1;12(7):839-46 – reference: 10965494 - Mol Med. 2000 Mar;6(3):179-95 – reference: 9151856 - J Virol. 1997 Jun;71(6):4626-37 – reference: 2760976 - J Virol. 1989 Sep;63(9):3612-21 – reference: 3003240 - J Gen Virol. 1986 Feb;67 ( Pt 2):321-32 – reference: 8942974 - Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13565-70 – reference: 8599194 - Virology. 1996 Mar 1;217(1):11-22 – reference: 8794347 - J Virol. 1996 Oct;70(10):7030-8 – reference: 8642665 - J Virol. 1996 Apr;70(4):2378-86 – reference: 9444984 - J Virol. 1998 Feb;72(2):926-33 – reference: 21416352 - Methods Mol Biol. 1991;7:109-28 – reference: 2325200 - J Virol. 1990 May;64(5):2047-56 – reference: 9094606 - J Virol. 1997 May;71(5):3375-84 – reference: 1136138 - Virology. 1975 Jul;66(1):10-24 – reference: 5669983 - Virology. 1968 Sep;36(1):126-36 |
| SSID | ssj0014464 |
| Score | 1.951579 |
| Snippet | Although it has been demonstrated that the adenovirus IVa2 protein binds to the packaging domains on the viral chromosome and interacts with the viral L1... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 10446 |
| SubjectTerms | Adenoviridae - physiology Capsid - physiology Cell Line DNA Replication DNA, Viral - physiology Humans Viral Proteins - physiology Virus Assembly |
| Title | Role for the adenovirus IVa2 protein in packaging of viral DNA |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/11581412 https://www.proquest.com/docview/71218838 |
| Volume | 75 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA7VKnjx_ajPHLxubbLJPkCUohYruBTRsreSZBMolt3a2oL_3kl2F0_iQQh7CyzDZOabzOT7ELqksVFc2q4uo8ZjAHo9GauOR2KtTMy0nW9yYhNhkkRpGg8a6Lp-C2PHKuuY6AJ1Vih7R34VEkhGkR_dTj88qxlle6uVgMYKavoAZKxPh-lPDwEKHVZzhcOxTivKUQjIV0_DfjvkbUpsi5MFEItYecFCfgeaLuH0tv73q9toswKauFt6xg5q6HwXrZfSk1976OalmGgMiBUDAsQCok-xHM8Wc9wfCoode8M4x7Cgpn53Ska4MNhOBE_wfdLdR2-9h9e7R6_SUvCUDyDKo4ZwbckDNdda-760uIoGyg-4VpGGuivTVr5RdFgYMM7DrEOVYoSYSAgJRcgBWs2LXB8hHJOMQZrPQsvFT2UgCDOZoJJSyST3eQtd1GYZga_aBoTIdbGYj2rDtNBhadnRtKTUgDqER4QRevzn3hO04cbA3HPAU9Q0cEr1GVpTy8_xfHbuXAC-yeD5GyfEtqE |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+for+the+adenovirus+IVa2+protein+in+packaging+of+viral+DNA&rft.jtitle=Journal+of+virology&rft.au=Zhang%2C+W&rft.au=Low%2C+J+A&rft.au=Christensen%2C+J+B&rft.au=Imperiale%2C+M+J&rft.date=2001-11-01&rft.issn=0022-538X&rft.volume=75&rft.issue=21&rft.spage=10446&rft_id=info:doi/10.1128%2FJVI.75.21.10446-10454.2001&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |